Indaptus Therapeutics, Inc. (INDP)
NCM · Common · CUSIP 45339J105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for INDP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45339J105
Market Cap
Micro Cap
Business: Indaptus Therapeutics immunotherapy approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously.

Company Contact

CEO
Jeffrey A. Meckler
CFO
Nir Sassi
Headquarters
3 Columbus Circle, 15th Floor, New York, NY 10019
Phone
646-427-2727
Investor Relations
Will O’Connor, Stern IR · 212-362-1200 · will@sternir.com
General Email
investors@indaptusrx.com
SEC EDGAR Filings
View filings »